SCHEMBL7053654

SCHEMBL7053654

COC(=O)c1cc2nc(-c3ccccc3)sc2cc1OC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 9/20 0.56
RAB9A P51151 9/20 0.56
NPC1 O15118 6/20 0.56
HPGD P15428 6/20 0.56
NFKB1 P19838 4/20 0.56
NFKB2 Q00653 4/20 0.56
RELA Q04206 4/20 0.56
PKM P14618 2/20 0.56
KDM4E B2RXH2 9/20 0.52
LMNA P02545 3/20 0.52
TRPM8 Q7Z2W7 1/20 0.51
MAPT P10636 5/20 0.50
KMT2A Q03164 3/20 0.50
ALDH1A1 P00352 5/20 0.49
TP53 P04637 3/20 0.49
MAPK1 P28482 2/20 0.49
MEN1 O00255 2/20 0.49
NOD2 Q9HC29 1/20 0.49
THRB P10828 1/20 0.48
L3MBTL1 Q9Y468 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9435301 0.91 KDM4E (0.57) SMN1; SMN2RAB9ANPC1HPGDNFKB1
SCHEMBL11239816 0.80 SMN1; SMN2 (0.50) SMN1; SMN2RAB9ANPC1HPGDNFKB1
SCHEMBL12596886 0.79 SMN1; SMN2 (0.74) SMN1; SMN2RAB9ANPC1HPGDNFKB1
SCHEMBL31025226 0.79 RAB9A (0.65) SMN1; SMN2RAB9ANPC1HPGDNFKB1
SCHEMBL7057299 0.78 SMN1; SMN2 (0.50) SMN1; SMN2RAB9ANPC1HPGDNFKB1
SCHEMBL7054374 0.78 SMN1; SMN2 (0.51) SMN1; SMN2RAB9ANPC1HPGDNFKB1
SCHEMBL6946336 0.77 KDM4E (0.59) SMN1; SMN2RAB9ANPC1HPGDNFKB1
SCHEMBL29226750 0.75 ILK (0.59) SMN1; SMN2RAB9ANPC1HPGDNFKB1
SCHEMBL19899923 0.74 STING1 (0.46) SMN1; SMN2RAB9ANPC1KDM4EMAPT
SCHEMBL3187010 0.73 KDM4E (0.68) SMN1; SMN2RAB9ANPC1HPGDNFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030162766-A1 Aminomethylene substituted non-aromatic heterocycles and use as substance P antagonists PFIZER INC. 2003-08-28 US disclosed
US-6369074-B1 Aminomethylene substituted non-aromatic heterocycles and use as substance P antagonists PFIZER INC. 2002-04-09 US disclosed
US-20010023248-A1 Aminomethylene substituted non-aromatic heterocycles and use as substance P antagonists HOWARD HARRY R (US) 2001-09-20 US disclosed
US-5854262-A Aminomethylene substituted non-aromatic heterocycles and use as substance P antagonists PFIZER INC. (US) 1998-12-29 US disclosed
EP-0806423-A1 Aminomethylene substituted non-aromatic heterocycles and use as substance p antagonists PFIZER INC. (US) 1997-11-12 EP disclosed
EP-0675886-A1 AMINOMETHYLENE SUBSTITUTED NON-AROMATIC HETEROCYCLES AND USE AS SUBSTANCE P ANTAGONISTS PFIZER INC. (US) 1995-10-11 EP disclosed
WO-1994013663-A1 AMINOMETHYLENE SUBSTITUTED NON-AROMATIC HETEROCYCLES AND USE AS SUBSTANCE P ANTAGONISTS PFIZER INC. (US) 1994-06-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010023248-A1 Aminomethylene substituted non-aromatic heterocycles and use as substance P antagonists NPY1R, OPRK1, OPRL1 SMN1; SMN2 1543/4885RAB9A 3335/4885NPC1 4173/4885
US-20030162766-A1 Aminomethylene substituted non-aromatic heterocycles and use as substance P antagonists NPY1R, OPRK1, TACR1 SMN1; SMN2 1485/4885RAB9A 3166/4885NPC1 4222/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.